Second-Line Therapies After Treatment with Fludarabine, Cyclophosphamide, and Rituximab (FCR) or Fludarabine and Cyclophosphamid Alone (FC) for Chronic Lymphocytic Leukemia (CLL) within the CLL8-Protocol of the German CLL Study Group (GCLLSG)

Konference: 2011 53rd ASH Annual Meeting – účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 642. CLL - Therapy, excluding Transplantation: Poster II

Číslo abstraktu: 2863

Autoři: MD Paula Cramer; MD Anna-Maria Fink; Dipl.Math. Raymonde Busch, Ph.D.; MD Barbara Eichhorst; MD Clement Martin Wendtner; MD Natali Pflug; Frederike Schubert; Prof. Dr. med. Hartmut Döhner (Doehner); MD Michael Rieger; MD Michael Kneba, PhD; prof. MUDr. Jiří Mayer, CSc.; Prof. MD Michael Hallek; M.D. Kirsten Fischer

Datum přednesení příspěvku: 11. 12. 2011